Vibalogics Revenue and Competitors
Estimated Revenue & Valuation
- Vibalogics's estimated annual revenue is currently $14.3M per year.
- Vibalogics's estimated revenue per employee is $279,608
Employee Data
- Vibalogics has 51 Employees.
- Vibalogics grew their employee count by -32% last year.
Vibalogics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Finance and Administration | Reveal Email/Phone |
2 | Head Building Engineering | Reveal Email/Phone |
3 | VP - Head Operations | Reveal Email/Phone |
4 | VP Global Sales | Reveal Email/Phone |
5 | Director Manufacturing Operations | Reveal Email/Phone |
6 | Assistant to the Managing Director | Reveal Email/Phone |
7 | Director Validation | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Manager Quality Control | Reveal Email/Phone |
10 | Manager Training & Compliance | Reveal Email/Phone |
Vibalogics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $36.9M | 277 | 21% | N/A | N/A |
#2 | $33.7M | 174 | -10% | $521.9M | N/A |
#3 | $52.4M | 321 | 16% | N/A | N/A |
#4 | $162.7M | 1219 | 33% | N/A | N/A |
#5 | $43.2M | 279 | 7% | N/A | N/A |
#6 | $1.1M | 7 | N/A | N/A | N/A |
#7 | $24.2M | 213 | 39% | N/A | N/A |
#8 | $19.7M | 117 | 13% | N/A | N/A |
#9 | $21.2M | 81 | -12% | $347.1M | N/A |
#10 | $18.3M | 118 | 7% | $197.4M | N/A |
What Is Vibalogics?
Vibalogics offers process development, cGMP manufacturing and fill/finish of products based on viruses for companies involved in the development of vaccines, gene and oncolytic viral therapies in the biopharmaceutical industry. Services include: • Feasibility assessment • Technology transfer • Process development • cGMP manufacturing • Formulation/blending • Fill/finish (including liquid and lyophilized formulations) • QC analysis • Product release The primary goal of the company is to offer a full range of development and manufacturing services to its customers, underpinned by excellent quality and a transparent customer experience. The drugs that Vibalogics develop and manufacture on behalf of its customers are predominantly destined for use in clinical trials with the final aim of commercialising new products for prophylactic or therapeutic vaccination and treatment of life-threatening diseases.
keywords:N/A
N/A
Total Funding
51
Number of Employees
$14.3M
Revenue (est)
-32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vibalogics News
Arranta specializes in microbiome therapeutic products and mRNA clinical production, while Vibalogics focuses on the production of oncolytic viruses, viral...
Vibalogics, a virotherapy contract development and manufacturing organization (CDMO) focused on the production of live viruses and viral...
Vibalogics, which was recently acquired by Swedish company, Recipharm, says the completion of its expansion project at its facility in...
Vibalogics GmbH, a contract development and manufacturing organization (CDMO) focused on complex live biological products, is being acquired by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the healthcare sector. Ampersand’s growth investment will ...